Corrigendum to "Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude mice" [Biomaterials (2016) 63-71]

Biomaterials. 2021 Apr:271:120744. doi: 10.1016/j.biomaterials.2021.120744. Epub 2021 Mar 15.

Authors

Bo Zhang¹, Ting Jiang¹, Xiao Jian She², Shun Shen², Sheng Wang², Jun Deng¹, Wei Shi¹, Heng Mei³, Yu Hu⁴, Zhiqing Pang², Xinguo Jiang²

Affiliations

¹ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430022, PR China.
² School of Pharmacy, Fudan University, Key Laboratory of Smart Drug Delivery, Ministry of Education, 826 Zhangheng Road, Shanghai, 201203, PR China.
³ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430022, PR China; Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, PR China.
⁴ Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430022, PR China; Collaborative Innovation Center of Hematology, Huazhong University of Science and Technology, PR China. Electronic address: [email protected].

PMID: 33735830
DOI: 10.1016/j.biomaterials.2021.120744

No abstract available

Publication types

Published Erratum